Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...

Researchers from Phoenixlab, The Scripps Research Institute and affiliated organizations presented the discovery of a novel bivalent protease-activated receptor PAR1- and PAR3-derived peptide, named ...

"The public can be assured that a great deal of care has been taken by the FDA to ensure that these bivalent COVID-19 vaccines meet our rigorous safety, effectiveness, and manufacturing quality ...

With validation of STEAP1 as a target, investigators want to know whether CAR T cells might be developed to target the ...

Obstetrical and Gynaecological Society of Bangladesh today said the human papillomavirus (HPV) vaccine is safe and effective ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Previously, the adjuvanted RSV prefusion F protein-based vaccine had been approved only for adults ages 60 and older. Then in ...

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to ...

Childhood vaccinations are crucial for protecting children from deadly infections. Vaccines work by stimulating the immune ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial ...